in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
ScinoPharm and Sundia establish alliance for contract research and manufacturing in China
9:58 AM MDT | August 7, 2013 | Deepti Ramesh
Active pharmaceutical ingredients (APIs) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says its ScinoPharm Changshu Pharmaceuticals (Changshu, China) subsidiary has entered into a strategic alliance with clinical research firm Sundia MediTech (Shanghai), to explore opportunities for collaboration in contract research and manufacturing services (Crams) in mainland China. The cooperation combines Sundia's technical know-how and capabilities in new drug R&D with ScinoPharm's process R&D and commercial production advantages, especially in the field of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee